Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 980163, 3 pages
http://dx.doi.org/10.1155/2014/980163
Editorial

Cancer Diagnostic and Predictive Biomarkers

1Department of Experimental Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy
2Department of Microbiology and Immunology, Institute of Human Virology, Baltimore, MD 21201, USA
3Department of Research, International Prevention Research Institute, 69006 Lyon, France
4Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy
5Department of Research, Sidra Medical and Research Center, 00974 Doha, Qatar

Received 4 March 2014; Accepted 4 March 2014; Published 3 April 2014

Copyright © 2014 Franco M. Buonaguro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. R. Srinivas, B. S. Kramer, and S. Srivastava, “Trends in biomarker research for cancer detection,” The Lancet Oncology, vol. 2, no. 11, pp. 698–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Tornesello, L. Buonaguro, F. Tatangelo, G. Botti, F. Izzo, and F. M. Buonaguro, “Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections,” Genomics, vol. 102, no. 2, pp. 74–83, 2013. View at Publisher · View at Google Scholar
  3. V. de Giorgi, L. Buonaguro, A. Worschech et al., “Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis,” PLoS ONE, vol. 8, no. 2, Article ID e56153, 2013. View at Publisher · View at Google Scholar